Journal Report

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Download PDF
Journal Information
Journal Title
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
Publisher
CIG MEDIA GROUP, LP
ISSN
2152-2650
E-ISSN
2152-2669
Database
Clarivate
Domain
Health Sciences, Life Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓
2021/2022 ✓
2020 ✓
2019 ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Matching-Adjusted Indirect Comparison of Gecacitinib Monotherapy versus Ruxolitinib Monotherapy and Pelabresib-Ruxolitinib Combination in JAK Inhibitor-Naive Myelofibrosis Patients
Yi Zhang, Hu Zhou, Junling Zhuang et al.
2026-10
DOI: 10.1016/j.clml.2026.10.012
Health-related quality of life with mosunetuzumab plus polatuzumab vedotin in R/R LBCL: Phase 3 SUNMO trial
Won-Seog Kim, Huilai Zhang, Dai Maruyama et al.
2026-10
DOI: 10.1016/j.clml.2026.10.009
Real-World Outcomes in First-Line Venetoclax-Based Therapy in Patients With AML Ineligible for Intensive Chemotherapy: A Single Center Study
Cheryl H. Chang, Allison O. Taylor, Nia M. Mitchell et al.
2026-10 Vol. 26 Issue 10 Pages 661-669
DOI: 10.1016/j.clml.2026.07.018
Revumenib in Pediatric Acute Leukemia: Clinical Activity and Differentiation Syndrome from the AUGMENT-101 Study
Branko Cuglievan, Samanta Catueno, Aziz Farhat et al.
2026-10
DOI: 10.1016/j.clml.2026.10.013
In Search of Long-Term Disease Control: CAR T-Cell Therapy With Axicabtagene Ciloleucel or Allogeneic Hematopoietic Cell Transplantation Against Relapsed/Refractory Large B-Cell Lymphoma
Markus Maulhardt, Lina J. Kolloch, Gina Westhofen et al.
2026-10 Vol. 26 Issue 10 Pages 670-688.e2
DOI: 10.1016/j.clml.2026.08.002
SOHO State of the Art Updates and Next Questions| Individualizing Treatment Selection in Myelofibrosis
Anthony M. Hunter, Prithviraj Bose
2026-10 Vol. 26 Issue 10 Pages 640-648
DOI: 10.1016/j.clml.2026.07.010
Use and safety of peripherally inserted venous catheters vs central venous catheters for patients with lymphoma receiving frontline anthracycline-based chemotherapy
Yun Kyoung Tiger, Danny Luan, Patrick Glennan et al.
2026-10
DOI: 10.1016/j.clml.2026.10.022
Targeting the Menin–KMT2A Axis in AML: Translating Molecular Insights into Therapeutic Success
Claudia Simio, Alessandra Vatteroni
2026-10 Vol. 26 Issue 10 Pages 649-660
DOI: 10.1016/j.clml.2026.07.019
Right ventricular global longitudinal strain derived by cardiac magnetic resonance in cardiac light-chain amyloidosis: improved prognostic model fit beyond staging and greater discrimination than echocardiography — a retrospective cohort study
Vasilis Mikros, Niki Lama, Georgios Georgiopoulos et al.
2026-10
DOI: 10.1016/j.clml.2026.10.015
Ataxia and Balance Disorders Associated with GPRC5D-Directed Therapies in Relapsed/Refractory Multiple Myeloma: A Case Series with Practical Recommendations for Management
Ja Min Byun, Vania Hungria, Niels W.C.J. van de Donk et al.
2026-10
DOI: 10.1016/j.clml.2026.10.019
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 1, 2026 03:14